Abstract
KEY POINTSA healthy 7-year-old girl received her first dose of Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in her upper arm. Forty-eight hours later, she developed localized erythema, induration and pruritic papular eruption at the injection site ([Figure 1][1]). There were no mucosal lesions, joint
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
